Clinical trials
Phase 1 Retinal Degeneration trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 3 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Gemini Therapeutics, Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| Opthea Limited | 1 |
| PYC Therapeutics | 1 |
| Quark Pharmaceuticals | 1 |
| University of California, Davis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Degeneration | 10 |
| Eye Diseases | 6 |
| Macular Degeneration | 6 |
| Retinal Diseases | 5 |
| Retinitis Pigmentosa | 2 |
| Blindness | 1 |
| Geographic Atrophy | 1 |
| Neovascularization, Pathologic | 1 |
| Optic Atrophy | 1 |
| Optic Atrophy, Hereditary, Leber | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.